Following breast cancer diagnosis, non-breast cancer causes of death represented a significant number of deaths in this population, providing crucial understanding on how survivors should be counseled on future health risks.
The criterion-based valuation framework was created with the intention of being revised as public feedback is ascertained and the landscape of cancer care evolves.
A study showed that acupuncture use brought a significant reduction in pain along with a decreased use of analgesics.
Authors indicated that reductions in smoking and treatment breakthroughs have led to this steady decline.
Largest analysis of data to date shows no link between use of talc powder and rate of ovarian cancer incidence
This study indicated the necessity for healthcare providers to initiate discussions on the experience of hearing loss for cancer survivors, as well as care options and interventions.
The FDA approved pembrolizumab for the treatment of patients with BCG–unresponsive, high-risk, non-muscle invasive bladder cancer with carcinoma in-situ with or without papillary tumors who are ineligible for or chose to not undergo cystectomy.
Results of this phase III trial could change the current standard of care for treating nonseminomatous or combined germ cell tumors of the testis.
Researchers found that patients in this study used a number of unsafe practices to limit opioid use, including turning to other substances to avoid “harder medicines.”
Researchers suggest that improved communication at the facility-level and health-system level could significantly improve the care of nursing home residents with poor-prognosis cancer.